Fundraising Fox
IRIS MEDICINE
11 employees on LinkedIn · 3 known investors
Find your way into IRIS MEDICINE
Sign up to see every warm intro you have to IRIS MEDICINE
- Paths you didn't know you had: your email and LinkedIn already hold routes to the IRIS MEDICINE team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
Founders & leadership
MM
Megan MatthewsCo-founder & President
MB
Megan BlewettFounder
Investors · 3
Frequently asked questions
- What does IRIS MEDICINE do?
- Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
- Who founded IRIS MEDICINE?
- IRIS MEDICINE was founded by Megan Matthews.
- Who are IRIS MEDICINE's investors?
- IRIS MEDICINE's investors include Venrock, UCB Ventures, PsyMed Ventures.